"Lewy Body Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A neurodegenerative disease characterized by dementia, mild parkinsonism, and fluctuations in attention and alertness. The neuropsychiatric manifestations tend to precede the onset of bradykinesia, MUSCLE RIGIDITY, and other extrapyramidal signs. DELUSIONS and visual HALLUCINATIONS are relatively frequent in this condition. Histologic examination reveals LEWY BODIES in the CEREBRAL CORTEX and BRAIN STEM. SENILE PLAQUES and other pathologic features characteristic of ALZHEIMER DISEASE may also be present. (From Neurology 1997;48:376-380; Neurology 1996;47:1113-1124)
| Descriptor ID |
D020961
|
| MeSH Number(s) |
C10.228.140.079.862.400 C10.228.140.380.422 C10.228.662.600.200 C10.574.531 F03.615.400.512
|
| Concept/Terms |
Lewy Body Disease- Lewy Body Disease
- Diffuse Lewy Body Disease
- Lewy Body Dementia
- Cortical Lewy Body Disease
- Lewy Body Disease, Cortical
- Lewy Body Type Senile Dementia
- Lewy Body Disease, Diffuse
- Dementia, Lewy Body
|
Below are MeSH descriptors whose meaning is more general than "Lewy Body Disease".
Below are MeSH descriptors whose meaning is more specific than "Lewy Body Disease".
This graph shows the total number of publications written about "Lewy Body Disease" by people in this website by year, and whether "Lewy Body Disease" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 3 | 2 | 5 |
| 2000 | 4 | 2 | 6 |
| 2001 | 2 | 1 | 3 |
| 2002 | 7 | 1 | 8 |
| 2003 | 4 | 4 | 8 |
| 2004 | 7 | 5 | 12 |
| 2005 | 2 | 2 | 4 |
| 2006 | 7 | 2 | 9 |
| 2007 | 7 | 2 | 9 |
| 2008 | 2 | 1 | 3 |
| 2009 | 5 | 1 | 6 |
| 2010 | 5 | 3 | 8 |
| 2011 | 6 | 5 | 11 |
| 2012 | 8 | 4 | 12 |
| 2013 | 8 | 4 | 12 |
| 2014 | 8 | 4 | 12 |
| 2015 | 13 | 1 | 14 |
| 2016 | 14 | 2 | 16 |
| 2017 | 12 | 1 | 13 |
| 2018 | 13 | 5 | 18 |
| 2019 | 14 | 7 | 21 |
| 2020 | 15 | 1 | 16 |
| 2021 | 12 | 1 | 13 |
| 2022 | 15 | 1 | 16 |
| 2023 | 15 | 0 | 15 |
| 2024 | 9 | 3 | 12 |
| 2025 | 2 | 0 | 2 |
Below are the most recent publications written about "Lewy Body Disease" by people in Profiles.
-
Hospice Use Among Medicare Beneficiaries With Parkinson Disease and Dementia With Lewy Bodies. JAMA Netw Open. 2025 Mar 03; 8(3):e250014.
-
Distinct subcellular localization of tau and alpha-synuclein in lewy body disease. Acta Neuropathol Commun. 2025 Jan 21; 13(1):14.
-
Concordance and test-retest consistency of sleep biomarker-based neurodegenerative disorder profiling. Sci Rep. 2024 12 28; 14(1):31234.
-
Cognitive decline profiles associated with lewy pathology in the context of Alzheimer's disease neuropathologic change. Alzheimers Res Ther. 2024 Dec 20; 16(1):270.
-
Orexin and Sleep Disturbances in Alpha-Synucleinopathies: a Systematic Review. Curr Neurol Neurosci Rep. 2024 Sep; 24(9):389-412.
-
Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy Bodies. Neurology. 2024 Aug 13; 103(3):e209656.
-
Cerebral Glucose Metabolism Is a Valuable Predictor of Survival in Patients with Lewy Body Diseases. Ann Neurol. 2024 Sep; 96(3):539-550.
-
Skin Biopsy Detection of Phosphorylated α-Synuclein in Patients With Synucleinopathies. JAMA. 2024 04 16; 331(15):1298-1306.
-
α-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway. Cell Death Dis. 2024 04 13; 15(4):264.
-
Clinicopathological correlation of cerebrospinal fluid alpha-synuclein seed amplification assay in a behavioral neurology autopsy cohort. Alzheimers Dement. 2024 05; 20(5):3334-3341.